Voyager Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
2.86 | 48.72 | -94.14% | 0.0321 | +8 788.15% |
| P/S |
|
1.51 | 33.75 | -95.52% |
|
|
| P/BV |
|
1.6 | 4.82 | -66.8% |
|
|
| P/FCF |
|
5.47 | 61 | -91.03% |
|
|
| Ev/Ebitda |
|
2.61 | -22.17 | -111.75% |
|
|
| Ev/S |
|
1.32 | 22.56 | -94.16% |
|
|
| Ev/FCF |
|
4.41 | 68.75 | -93.58% |
|
|
| E/P |
|
0.3238 | 0.0178 | 1721.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
50.58 | 4.98 | 916.29% | -142.07 | -135.6% |
| ROE |
|
56 | 9.61 | 482.59% |
|
|
| ROA |
|
37.67 | 0.3443 | 10842.53% |
|
|
| ROIC |
|
-46.82 | 7.63 | -713.28% |
|
|
| ROS |
|
52.93 | -25.17 | -310.29% |
|
|
| ROCE |
|
51.63 | 15.35 | 236.35% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1605 | -3.68 | -104.37% | -0.1411 | -213.71% |
| Nеt Debt/Ebitda |
|
-0.3836 | -3.44 | -88.84% |
|
|
| Debt/Ratio |
|
0.0578 | 0.1985 | -70.89% |
|
|
| Debt/Equity |
|
1.13 | 1.51 | -25.01% |
|
|
| Debt/Net Income |
|
0.1534 | 10.32 | -98.51% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
140.39 | -56.89 | -346.77% | ||
| Growth impulse Ebitda in 5 years |
|
-409.7 | -54.68 | 649.27% | ||
| Growth impulse Net Income in 5 years |
|
-400.75 | -58.33 | 587.04% | ||
| Growth impulse FCF in 5 years |
|
82.1 | -49.48 | -265.93% | ||
| Growth impulse EPS in 5 years |
|
-345.38 | -32.41 | 965.66% |
IP Score
6.19/10
